logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Company in focus, Offsprings
Parent entities and officers 17
  • 1
    Mccarthy, Thomas David
    Born in June 1967
    Individual (12 offsprings)
    Officer
    2017-09-29 ~ now
    OF - Director → CIF 0
    Thomas David Mccarthy
    Born in June 1967
    Individual (12 offsprings)
    Person with significant control
    2017-09-29 ~ 2018-03-29
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 2
    Nasrallah, Rabab
    Born in August 1986
    Individual (2 offsprings)
    Officer
    2022-12-23 ~ now
    OF - Director → CIF 0
  • 3
    Joyce, Peter
    Born in April 1982
    Individual (3 offsprings)
    Officer
    2017-09-29 ~ now
    OF - Director → CIF 0
    Mr Peter Joyce
    Born in April 1982
    Individual (3 offsprings)
    Person with significant control
    2017-09-29 ~ 2018-03-29
    PE - Ownership of voting rights - More than 50% but less than 75% → CIF 0
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
    PE - Right to appoint or remove directors → CIF 0
  • 4
    Johnson, Emma
    Born in June 1996
    Individual (8 offsprings)
    Officer
    2022-12-23 ~ 2025-12-10
    OF - Director → CIF 0
  • 5
    Harris, Samantha Ann
    Individual (4 offsprings)
    Officer
    2022-06-22 ~ 2025-03-01
    OF - Secretary → CIF 0
  • 6
    Smirnyagina, Ekaterina, Dr
    Born in August 1966
    Individual (5 offsprings)
    Officer
    2024-11-25 ~ now
    OF - Director → CIF 0
  • 7
    Hercend, Thierry, Dr
    Born in March 1952
    Individual (1 offspring)
    Officer
    2018-03-29 ~ now
    OF - Director → CIF 0
  • 8
    Dewhurst, Sally Marianne, Dr.
    Born in March 1990
    Individual (3 offsprings)
    Officer
    2022-12-23 ~ 2024-11-25
    OF - Director → CIF 0
  • 9
    Marchington, Allan Patrick, Dr
    Born in July 1966
    Individual (17 offsprings)
    Officer
    2026-03-02 ~ now
    OF - Director → CIF 0
  • 10
    Weightman, Tracy
    Born in November 1979
    Individual (2 offsprings)
    Officer
    2024-05-15 ~ 2026-03-02
    OF - Director → CIF 0
  • 11
    Onions, Stuart Thomas
    Born in July 1979
    Individual (6 offsprings)
    Officer
    2018-03-18 ~ 2018-03-29
    OF - Director → CIF 0
  • 12
    Peakman, Marie-claire
    Born in July 1969
    Individual (3 offsprings)
    Officer
    2022-12-23 ~ now
    OF - Director → CIF 0
  • 13
    Wisniewski, Raphael
    Born in April 1970
    Individual (3 offsprings)
    Officer
    2018-03-29 ~ now
    OF - Director → CIF 0
  • 14
    Ahrens, Brenton Karl
    Born in March 1963
    Individual (3 offsprings)
    Officer
    2018-03-29 ~ now
    OF - Director → CIF 0
  • 15
    Stainer, Paul John Grattan
    Individual (1 offspring)
    Officer
    2025-05-01 ~ now
    OF - Secretary → CIF 0
  • 16
    2765, Sand Hill Rd, Menlo Park, California, United States
    Corporate (2 offsprings)
    Person with significant control
    2019-02-12 ~ 2019-02-12
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
  • 17
    374, Rue Saint-honore, Paris, 75001, France
    Corporate (1 offspring)
    Person with significant control
    2019-02-12 ~ 2019-02-12
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
parent relation
Company in focus

GREY WOLF THERAPEUTICS LIMITED

Period: 2017-09-29 ~ now
Company number: 10989365
Registered name
GREY WOLF THERAPEUTICS LIMITED - now
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
192024-01-01 ~ 2024-12-31
182023-01-01 ~ 2023-12-31
Property, Plant & Equipment
62,874 GBP2024-12-31
57,111 GBP2023-12-31
Fixed Assets - Investments
5 GBP2024-12-31
5 GBP2023-12-31
Fixed Assets
62,879 GBP2024-12-31
57,116 GBP2023-12-31
Debtors
Current
8,421,305 GBP2024-12-31
6,606,933 GBP2023-12-31
Cash at bank and in hand
20,417,134 GBP2024-12-31
9,031,259 GBP2023-12-31
Current Assets
28,838,439 GBP2024-12-31
15,638,192 GBP2023-12-31
Net Current Assets/Liabilities
26,225,233 GBP2024-12-31
11,393,395 GBP2023-12-31
Net Assets/Liabilities
26,288,112 GBP2024-12-31
11,450,511 GBP2023-12-31
Equity
Called up share capital
2,495 GBP2024-12-31
1,557 GBP2023-12-31
1,092 GBP2023-01-01
Share premium
86,763,972 GBP2024-12-31
50,485,036 GBP2023-12-31
31,345,805 GBP2023-01-01
Capital redemption reserve
3 GBP2024-12-31
3 GBP2023-12-31
3 GBP2023-01-01
Other miscellaneous reserve
1,546,849 GBP2024-12-31
Retained earnings (accumulated losses)
-62,025,207 GBP2024-12-31
-39,036,085 GBP2023-12-31
-22,956,771 GBP2023-01-01
Equity
26,288,112 GBP2024-12-31
11,450,511 GBP2023-12-31
8,390,129 GBP2023-01-01
Profit/Loss
Retained earnings (accumulated losses)
-22,989,122 GBP2024-01-01 ~ 2024-12-31
-16,079,314 GBP2023-01-01 ~ 2023-12-31
Profit/Loss
-22,989,122 GBP2024-01-01 ~ 2024-12-31
-16,079,314 GBP2023-01-01 ~ 2023-12-31
Issue of Equity Instruments
Called up share capital
938 GBP2024-01-01 ~ 2024-12-31
465 GBP2023-01-01 ~ 2023-12-31
Issue of Equity Instruments
36,279,874 GBP2024-01-01 ~ 2024-12-31
19,139,696 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Gross Cost
Office equipment
48,803 GBP2024-12-31
48,803 GBP2023-12-31
Computers
91,001 GBP2024-12-31
46,499 GBP2023-12-31
Other
77,556 GBP2024-12-31
77,556 GBP2023-12-31
Property, Plant & Equipment - Gross Cost
217,360 GBP2024-12-31
172,858 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Office equipment
43,869 GBP2024-12-31
34,429 GBP2023-12-31
Computers
39,773 GBP2024-12-31
26,454 GBP2023-12-31
Other
70,844 GBP2024-12-31
54,864 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
154,486 GBP2024-12-31
115,747 GBP2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Office equipment, Owned/Freehold
9,440 GBP2024-01-01 ~ 2024-12-31
Computers, Owned/Freehold
13,319 GBP2024-01-01 ~ 2024-12-31
Owned/Freehold
38,739 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment
Office equipment
4,934 GBP2024-12-31
14,374 GBP2023-12-31
Computers
51,228 GBP2024-12-31
20,045 GBP2023-12-31
Other
6,712 GBP2024-12-31
22,692 GBP2023-12-31
Amounts Owed by Group Undertakings
Current
934,519 GBP2024-12-31
424,990 GBP2023-12-31
Other Debtors
Current
1,550,302 GBP2024-12-31
3,923,864 GBP2023-12-31
Prepayments/Accrued Income
Current
497,725 GBP2024-12-31
197,231 GBP2023-12-31
Amount of corporation tax that is recoverable
Current
5,438,759 GBP2024-12-31
2,060,848 GBP2023-12-31
Trade Creditors/Trade Payables
Current
1,635,506 GBP2024-12-31
1,337,066 GBP2023-12-31
Taxation/Social Security Payable
Current
439,759 GBP2024-12-31
268,684 GBP2023-12-31
Other Creditors
Current
9,872 GBP2024-12-31
1,922,825 GBP2023-12-31
Accrued Liabilities/Deferred Income
Current
528,069 GBP2024-12-31
716,222 GBP2023-12-31
Creditors
Current
2,613,206 GBP2024-12-31
4,244,797 GBP2023-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
1,721,558 shares2024-12-31
1,688,500 shares2023-12-31
Par Value of Share
Class 1 ordinary share
0.00012024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
3,597,122 shares2024-12-31
3,597,100 shares2023-12-31
Par Value of Share
Class 2 ordinary share
0.00012024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
691,755 shares2024-12-31
691,800 shares2023-12-31
Par Value of Share
Class 3 ordinary share
0.00012024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 4 ordinary share
2,454,223 shares2024-12-31
2,454,200 shares2023-12-31
Par Value of Share
Class 4 ordinary share
0.00012024-01-01 ~ 2024-12-31
  • GREY WOLF THERAPEUTICS LIMITED
    Info
    Registered number 10989365
    99 Park Drive, Milton, Abingdon OX14 4RY
    PRIVATE LIMITED COMPANY incorporated on 2017-09-29 (8 years 8 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-10-27
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.